Innovation – Open view page

General information

Innovation ID561
Version ID431
Innovation TitleChickpea inbred variety NBeG 452 for cultivation in the dry lowlands in India
Innovation description NBeG 452 is a high-yielding (2.2 to 2.3 mt/ha) short duration rainfed chickpea variety. It is resistant to wilt, and has tolerance to drought. This variety produces grains with high digestibility, and high protein content. This variety will potentially contribute to SDG`s 1,2,3,12, and 17.
Reporting Staff Srinivasan Samineni (ICRISAT)
Year (Reporting)2020
Reporting statusApproved
Innovation TypeGenetic (variety and breeds)
Number of varieties1

Stage reached

Stage of InnovationStage 3: available/ ready for uptake
Year (Stage)2020
Stage DescriptionCrossing of the parents of this variety was done in 2003 followed by bulk selection, single plant selection, then advanced field trials before it was released on August 6, 2020 cultivation in Andhra Pradesh, India. This variety is positioned to replace old varieties Annigeri, JG 11, and JAKI 9218.
Has a lead organizationyes
Lead OrganizationAcharya N.G. Ranga Agricultural University
Top 5 contributorsInternational Crops Research Institute for the Semi-Arid Tropics; Indian Council of Agricultural Research

Contributions and mapping

All partners
Main CRP CGIAR Research Program on Grain Legumes and Dryland Cereals
Flagship project FP4-Variety and Hybrid Development
Cluster FP4-2-Breeding pipelines
Other CRPs-Flagships-Clusters

Scope

Geographic scopeNational
Regions
CountriesIndia

Targeted outcomes

Main Sub-IDO Enhanced genetic gain
Other Sub-IDO Closed yield gaps through improved agronomic and animal husbandry practices
Other Sub-IDO Reduced production risk

Evidences

EvidencesList of varieties released by ICRISAT (GLDC-mapped) 2020 from MEASURE Platform
[https://mel.cgiar.org/uploads/relatedfiles/jhF3fH3GLzIx9UvsOqbzlMPwA0MDgf.xlsx]

Linked Elements

Milestones6814-172-37920 - New suite of resilient varieties released by NARS partners. (Phase 1 investments start being released)
Outcome Impact Case
Policy